Frans M. J. Debruyne
#122,974
Most Influential Person Now
Frans M. J. Debruyne's AcademicInfluence.com Rankings
Frans M. J. Debruynemedical Degrees
Medical
#1907
World Rank
#2292
Historical Rank
Urology
#11
World Rank
#12
Historical Rank
Frans M. J. Debruynephilosophy Degrees
Philosophy
#5629
World Rank
#8486
Historical Rank
Logic
#2865
World Rank
#3935
Historical Rank
Download Badge
Medical Philosophy
Frans M. J. Debruyne's Degrees
- Doctorate Medicine University of Amsterdam
- PhD Urology University of Amsterdam
Why Is Frans M. J. Debruyne Influential?
(Suggest an Edit or Addition)Frans M. J. Debruyne's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. (1999) (1080)
- Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. (1992) (694)
- Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. (1992) (648)
- Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. (1994) (566)
- Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. (1993) (390)
- Factors affecting recurrence and progression in superficial bladder tumours. (1995) (290)
- 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer (2000) (248)
- Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic Hyperplasia (1998) (242)
- Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. (1993) (221)
- Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. (1996) (213)
- Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. (2001) (213)
- Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia (2004) (209)
- Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. (1992) (208)
- [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]. (2002) (202)
- Molecular genetics and epidemiology of prostate carcinoma. (1999) (195)
- Decreased expression of E-cadherin in the progression of rat prostatic cancer. (1992) (194)
- Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. (1993) (183)
- HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS (1996) (183)
- Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations (2018) (172)
- Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. (1997) (171)
- Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. (1994) (162)
- Treatment of mid- and lower ureteric calculi: extracorporeal shock-wave lithotripsy vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness. (1998) (156)
- Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. (1993) (153)
- Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? (2006) (137)
- Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization (1997) (136)
- The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group. (1993) (135)
- Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. (1995) (133)
- The effects of treatment of urinary incontinence in general practice. (1992) (131)
- Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. (1998) (131)
- A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder. (1995) (126)
- Controlled trial of pelvic floor exercises in the treatment of urinary stress incontinence in general practice. (1991) (124)
- Posterior tibial nerve stimulation in the treatment of urge incontinence (2003) (122)
- fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. (1987) (121)
- Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. (1991) (118)
- Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer (2005) (117)
- Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. (1999) (116)
- Alpha blockers: are all created equal? (2000) (116)
- Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. (1996) (115)
- Acoustic analysis of the speaking voice after thyroidectomy. (1997) (114)
- Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. (2003) (107)
- Microvessel Density: Correlation between Contrast Ultrasonography and Histology of Prostate Cancer (2001) (102)
- Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. (2003) (102)
- Influence of high-intensity focused ultrasound on the development of metastases. (1997) (101)
- Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. (1994) (99)
- Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. (1998) (98)
- Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study (2002) (98)
- Chromosomal analysis of bladder cancer. III. Nonrandom alterations. (1987) (98)
- Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. (1996) (97)
- Acoustic analysis of tracheo-oesophageal versus oesophageal speech (1994) (96)
- Parathyroidectomy after successful kidney transplantation: a single centre study. (2007) (95)
- Assessment of penile blood flow by duplex ultrasonography in 44 men with normal erectile potency in different phases of erection. (1992) (95)
- Erectile dysfunction in diabetic men: the neurological factor revisited. (1994) (95)
- Extracorporeal shock wave lithotripsy for large renal calculi: the role of ureteral stents. A randomized trial. (1991) (93)
- Grading in superficial bladder cancer. (1). Morphological criteria. (1988) (91)
- Value of the patient's case history in diagnosing urinary incontinence in general practice. (1991) (88)
- Long-term results of ileum interposition for ureteral obstruction. (2002) (86)
- Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. (1991) (85)
- Epidemiology of prostate cancer. (1996) (85)
- Potential occupational health problems for dentists in Flanders, Belgium (2005) (82)
- Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer (1991) (80)
- Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin (2005) (78)
- Some Limitations of the Radioisotope Bone Scan in Patients With Metastatic Prostatic Cancer (1990) (78)
- Selective stimulation of sacral nerve roots for bladder control: A study by computer modeling (1994) (75)
- Rapid microwave‐stimulated fixation of entire prostatectomy specimens (1997) (74)
- Sensorineural hearing loss in sporadic congenital hypothyroidism. (1983) (73)
- Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men (2017) (72)
- Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer. (1998) (72)
- Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. (1994) (69)
- A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. (1996) (69)
- Polymorphisms in the Vitamin D Receptor Gene and the Androgen Receptor Gene and the Risk of Benign Prostatic Hyperplasia (2000) (67)
- Seminal vesicle cyst with ipsilateral renal agenesis. (1993) (66)
- Renal trauma and hypertension. (1989) (66)
- Ciprofloxacin distribution in prostatic tissue and fluid following oral administration. (1985) (65)
- Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. (2004) (61)
- Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia. (1995) (60)
- Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate. (1997) (60)
- Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetate. (1987) (59)
- p53 mutations have no additional prognostic value over stage in bladder cancer. (1994) (59)
- Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects. (1995) (59)
- The role of nocturia in the quality of life of men with lower urinary tract symptoms (2010) (58)
- The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study. (1995) (58)
- Selective detrusor activation by electrical sacral nerve root stimulation in spinal cord injury. (1997) (57)
- Expert Opinion on Optimal Testosterone Control in Prostate Cancer (2005) (56)
- The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. (1996) (54)
- A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group. (1993) (54)
- Penile sensory disorders in erectile dysfunction: results of a comprehensive neuro-urophysiological diagnostic evaluation in 123 patients. (1991) (54)
- Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer. (2006) (54)
- The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group. (1996) (53)
- Arteria lusoria identified on preoperative CT and nonrecurrent inferior laryngeal nerve during thyroidectomy: A retrospective study (2003) (53)
- Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction. (2003) (52)
- The influence of high-energy shock waves on the development of metastases. (1996) (52)
- In vivo effects of high energy shock waves on urological tumors: an evaluation of treatment modalities. (1990) (52)
- Radical Hysterectomy And The Function Of The Lower Urinary Tract: Urodynamic Quantification Of Changes In Storage And Evacuation Function (1989) (52)
- Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. (2004) (50)
- The ageing voice: changes in fundamental frequency, waveform stability and spectrum. (1997) (50)
- Prognostic factors in superficial bladder cancer. A review. (1992) (50)
- Decreased expression of α‐catenin is associated with poor prognosis of patients with localized renal cell carcinoma (1997) (50)
- Hearing in congenital hypothyroidism. (1983) (50)
- Is detrusor instability in elderly males related to the grade of obstruction? (1995) (50)
- Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy. (1999) (48)
- Fibroepithelial polyp of ureter. (1980) (47)
- The morbidity due to lower urinary tract function in spinal cord injury patients (1993) (47)
- Longitudinal voice changes: facts and interpretation. (2000) (46)
- Speaking fundamental frequency in monozygotic and dizygotic twins. (2002) (46)
- Urinary NMP22TM and Karyometry in the Diagnosis and Follow-Up of Patients with Superficial Bladder Cancer (1998) (45)
- Cytotoxic effects of high energy shock waves in different in vitro models: influence of the experimental set-up. (1991) (45)
- Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer. (1996) (45)
- Extended bladder neck incision for outflow obstruction in male patients. (1983) (43)
- Quantitative light microscopy in urological oncology. (1992) (43)
- Penile pharmacological duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1. (1992) (42)
- BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial. (1988) (42)
- Bladder carcinoma in patients less than 40 years of age. (1989) (42)
- Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma. (1988) (42)
- Selective sacral root stimulation for bladder control: acute experiments in an animal model. (1994) (42)
- Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig. (1992) (42)
- Hormonal therapy of prostate cancer. (2002) (42)
- Comparison of biothesiometry and neuro-urophysiological investigations for the clinical evaluation of patients with erectile dysfunction. (1995) (42)
- Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group. (1998) (42)
- Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene (2004) (41)
- Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression. (1985) (41)
- Chylous ascites after retroperitoneal lymph node dissection. (1984) (41)
- Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia. (2008) (41)
- High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms. (1997) (41)
- The use of local anesthesia in second generation extracorporeal shock wave lithotripsy: eutectic mixture of local anesthetics. (1991) (40)
- The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma. (1995) (40)
- Binaural interaction in early, middle and late auditory evoked responses. (1984) (40)
- Voice similarity in identical twins. (2001) (40)
- In-use evaluation of the Omnicon automated tumor colony counter. (1983) (39)
- Acute animal studies on the use of an anodal block to reduce urethral resistance in sacral root stimulation (1994) (39)
- Treatment of stones in caliceal diverticula: extracorporeal shock wave lithotripsy versus percutaneous nephrolitholapaxy. (1992) (39)
- The effect of sustained phonation at high and low pitch on vocal jitter and shimmer. (1993) (39)
- Effects of high-energy shock waves combined with biological response modifiers in different human kidney cancer xenografts. (1991) (38)
- Holmium:YAG laser for treatment of strictures of vesicourethral anastomosis after radical prostatectomy. (2005) (38)
- Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas. (1994) (38)
- TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. (1988) (37)
- Alterations in Expression of Cadherin–6 and E–Cadherin during Kidney Development and in Renal Cell Carcinoma (2000) (37)
- In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. (1999) (36)
- Bladder pressure sensors in an animal model. (1994) (36)
- Selective detrusor activation by electrical stimulation of the human sacral nerve roots. (1997) (35)
- The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. (2010) (35)
- European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy. (2017) (34)
- Bladder compliance after posterior sacral root rhizotomies and anterior sacral root stimulation. (1994) (34)
- Psychological aspects of female urinary incontinence in general practice. (1992) (34)
- A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer. (1996) (33)
- The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in Patients with urine proven sterile prior to treatment (1997) (33)
- Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. (2011) (33)
- Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. (1990) (33)
- Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma. (1998) (32)
- The Value of lntravesical Prostaglandin E2and F2αin Women with Abnormalities of Bladder Emptying (1981) (32)
- Homozygous deletions of p16INK4 occur frequently in bilharziasis‐associated bladder cancer (1996) (32)
- Intermediate filament proteins as tissue specific markers in normal and malignant urological tissues. (1986) (32)
- The middle ear of cleft palate patients in their early teens: a literature study and preliminary file study. (2006) (31)
- Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. (2006) (31)
- Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch South East Cooperative Urological Group. (1996) (31)
- Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization. International Anandron Study Group. (1997) (31)
- Urinary incontinence caused by prazosin. (1978) (31)
- Prognostic value of karyometric and clinical characteristics in renal cell carcinoma quantitative assessment of tumor heterogeneity (1993) (30)
- Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts. (1998) (30)
- Random bladder biopsies and the risk of recurrent superficial bladder cancer: a prospective study in 1026 patients (1992) (30)
- Urethroplasty using the pedicled island flap technique in complicated urethral strictures. (1991) (30)
- Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression? (1998) (29)
- Ultrasonic determination of prostatic volume: a cadaver study. (1989) (29)
- Tissue‐specific markers in flow cytometry of urological cancers. III. Comparing chromosomal and flow cytometric dna analysis of bladder tumors (1987) (29)
- Selective detrusor activation by sacral ventral nerve-root stimulation: results of intraoperative testing in humans during implantation of a Finetech-Brindley system (1998) (29)
- Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer. (1996) (29)
- Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting. (2005) (29)
- Transurethral microwave thermotherapy in symptomatic benign prostatic hyperplasia. (1993) (29)
- Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients (1994) (29)
- Application of antibodies to intermediate filament proteins as tissue-specific probes in the flow cytometric analysis of complex tumors. (1986) (28)
- Sacral rhizotomies and electrical bladder stimulation in spinal cord injury. Part I: Clinical and urodynamic analysis. Dutch Study Group on Sacral Anterior Root Stimulation. (1998) (28)
- Can histopathology predict treatment outcome following high‐energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study (1999) (28)
- Mitomycin versus Bacillus Calmette Guerin Tice versus Bacillus Calmette Guerin RIVM in the treatment of patients with pTa-pT1 papillary carcinoma an carcinoma in situ of the urinary bladder (1996) (28)
- Influence of age and hearing loss on the latency shifts of the auditory brainstem response as a result of increased stimulus rate. (1986) (28)
- Diagnosis and treatment of urological complications in kidney transplantation. (1992) (28)
- Spontaneous renal decapsulation with excessive fluid leakage after transplantation. (1979) (28)
- Bladder neck incision in the female: a hazardous procedure? (1983) (27)
- Establishment and characterization of five new human renal tumor xenografts. (1992) (27)
- A Randomized Study Comparing High–Energy TUMT to TURP: Quality–of–Life Results (2000) (27)
- Update on the Dutch Cooperative Trial: Mitomycin versus Bacillus calemtte Guerin Tice versus Bacillus Calmette Guerin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder (1996) (27)
- Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study. (2011) (27)
- Flavoxate hydrochloride in the treatment of detrusor instability. (1977) (26)
- Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250. (1999) (26)
- Alpha and gamma interferon in the treatment of advanced renal cell carcinoma. (1988) (26)
- Cytogenetic analysis in urothelial cell carcinoma. (1987) (26)
- Intravesical therapy in superficial bladder cancer. (1994) (26)
- A Computer model of the neural control of the lower urinary tract (1998) (25)
- Non‐Radical Hysterectomy And The Function Of The Lower Urinary Tract: I: Urodynamic Quantification Of Changes In Storage Function (1989) (25)
- Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma. (1989) (25)
- The possible influence of antibiotics on results of bacillus Calmette-Guérin intravesical therapy for superficial bladder cancer. (1991) (25)
- Anterior vaginal repair, cause of troublesome voiding disorders? (1979) (25)
- Clinical and socioeconomic relevance of overactive bladder. (2004) (25)
- High-Intensity Focused Ultrasound (HIFU) Followed After One to Two Weeks by Radical Retropubic Prostatectomy: Results of a Prospective Study (1999) (25)
- Low–Dose Oxybutynin for the Treatment of Urge Incontinence: Good Efficacy and Few Side Effects (2000) (25)
- Non‐Radical Hysterectomy And The Function Of The Lower Urinary Tract: II: Urodynamic Quantification Of Changes In Evacuation Function (1989) (24)
- Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. (1998) (24)
- Role of testosterone in managing advanced prostate cancer. (2012) (24)
- Lower-energy thermotherapy in the treatment of benign prostatic hyperplasia: long-term follow-up results of a multicenter international study (1999) (24)
- Conventional bladder wash cytology performed by four experts versus quantitative image analysis. (1997) (24)
- Risk factors in carcinoma in situ of the urinary bladder. Commentary (1995) (24)
- Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study. (1993) (24)
- Critical review of the models to study the biologic progression of bladder cancer. (1992) (23)
- Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer. (1998) (23)
- The efficacy of GR38032F, an antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomiting. (1988) (23)
- The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment. (1998) (23)
- Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview. (1989) (23)
- Gonadotropin-releasing hormone antagonist in the management of prostate cancer. (2004) (23)
- Dose-ranging study of the luteinizing hormone-releasing hormone receptor antagonist cetrorelix pamoate in the treatment of patients with symptomatic benign prostatic hyperplasia. (2010) (23)
- Changes in keratin expression during the development of benign prostatic hyperplasia. (1997) (22)
- A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter study. (1996) (22)
- Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). (2017) (22)
- Uretero-neo-cystostomy in renal transplantation. Is an antireflux mechanism mandatory? (1978) (22)
- Advances and trends in hormonal therapy for advanced prostate cancer. (1995) (22)
- Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. (2002) (22)
- The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer. (1994) (22)
- On-effect in brainstem electric response audiometry. Consequences for the use of tone-bursts. (1982) (22)
- Motor evoked potentials from the bladder on magnetic stimulation of the cauda equina: a new technique for investigation of autonomic bladder innervation. (1992) (22)
- Bacillus Calmette-Guérin versus mitomycin intravesical therapy in superficial bladder cancer (1992) (21)
- Early metabolic response to high energy shock waves in a human tumor kidney xenograft monitored by 31P magnetic resonance spectroscopy. (1991) (21)
- Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin. (1991) (21)
- Aetiology of congenital hearing loss: a cohort review of 569 subjects. (2013) (21)
- Antibodies to cytokeratin and vimentin in testicular tumour diagnosis (2004) (21)
- Effect of adenotonsillectomy on the use of respiratory medication. (2012) (21)
- Changes in spectral measures and voice-onset time with age: a cross-sectional and a longitudinal study. (1997) (20)
- Temporary voice changes after uncomplicated thyroidectomy. (1997) (20)
- In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines (1995) (20)
- The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. (1996) (20)
- Comparison of tissue disaggregation techniques of transitional cell bladder carcinomas for flow cytometry and chromosomal analysis. (1987) (20)
- Grading in superficial bladder cancer. (2). Cytogenetic classification. (1988) (20)
- HLA‐class‐I and‐class‐II expression on renal tumor xenografts and the relation to sensitivity for α‐IFN, γ‐IFN and TNF (1991) (20)
- Bacillus Calmette-Guérin in superficial bladder cancer: consensus and controversies. (1995) (20)
- Molecular prognostic factors in bladder cancer (2004) (20)
- Endocrine approaches in the therapy of prostate carcinoma. (2005) (19)
- Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladder. (1991) (19)
- Otorrhea during transtympanal ventilation. (1988) (19)
- Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin (2005) (19)
- Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group. (1993) (18)
- Prolonged bladder distension in the management of the unstable bladder. (1980) (18)
- The Future of Urology in Europe: An Overview from the European Association of Urology (2001) (18)
- The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R3327 PAT-2 rat prostatic cancer cell-line (2004) (18)
- Treatment of Proximal and Midureteral Calculi: A Randomized Trial of In Situ and Pushback Extracorporeal Lithotripsy (1990) (18)
- Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experience. (1991) (18)
- Clinical Experience in Europe with Uroselective α1-Antagonists (1999) (18)
- Experimental models of bladder cancer: a critical review. (1986) (18)
- Androgens and Benign Prostatic Hyperplasia (2006) (18)
- Intra‐prostatic vasculature studies: Can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction? (2001) (17)
- Brown tumour: presenting symptom of primary hyperparathyroidism. (2005) (17)
- Incidence of multiglandular disease in sporadic primary hyperparathyroidism. (2014) (17)
- Cell DNA content — Correlation with clonogenicity in the human tumour cloning system (HTCS) (1985) (17)
- Antegrade percutaneous dilation of ureteral strictures after kidney transplantation (1989) (16)
- Intradural sacral rhizotomies and implantation of an anterior sacral root stimulator in the treatment of neurogenic bladder dysfunction after spinal cord injury (1991) (16)
- Retroperitoneal fibrosis in the scrotum. (1982) (16)
- Radiolabeled monoclonal antibody G250 in renal-cell carcinoma (2004) (16)
- Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer. (1995) (16)
- Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group. (1989) (16)
- Recurrent pancreatitis after trimethoprim-sulfamethoxazole rechallenge. (2005) (16)
- Enhanced pharmacological testing in patients with erectile dysfunction. (1995) (16)
- Postoperative course of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism. (2001) (16)
- Parathyroid function in the early postoperative period after thyroidectomy. (2001) (15)
- Rational guidelines in renal trauma assessment. (1989) (15)
- Completion thyroidectomy after the unexpected diagnosis of thyroid cancer. (2005) (15)
- Blood group isoantigen deletion and chromosomal abnormalities in bladder cancer. (1988) (15)
- Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas. (1998) (15)
- The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma (1993) (15)
- Synergistic Antitumor Effects of Rat γ-Interferon and Human Tumor Necrosis Factor α against Androgen-dependent and -independent Rat Prostatic Tumors (1991) (15)
- Acoustic differences between sustained vowels perceived as young or old (1999) (15)
- The use of indomethacin in the treatment of idiopathic bladder instability. (1981) (15)
- Chromosomal analysis of bladder cancer. II. A practical method. (1987) (15)
- A practical guide to the use of intravesical BCG for the management of stage Ta, T1, CIS, transitional cell cancer. (1989) (15)
- Hydronephrosis caused by cystocele. Treatment by colpopexy to sacral promontory. (1984) (14)
- [Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis]. (2004) (14)
- Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma. (1998) (14)
- Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. (2002) (14)
- Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt. (2000) (14)
- Audex Medical, a new system for digital processing and analysis of ultrasonographic images of the prostate. (1991) (14)
- Levothyroxine replacement therapy after thyroid surgery. (2006) (14)
- One-year follow-up after tympanostomy tube insertion for recurrent acute otitis media. (1993) (14)
- Branching Activity in the Human Prostate: A Closer Look at the Structure of Small Glandular Buds (2001) (14)
- Prognostic factors in superficial bladder cancer. (1986) (14)
- Factors determining the outcome following implantation of the AMS 800 artificial urinary sphincter. (1989) (14)
- Cold knife optical urethrotomy. (1979) (14)
- Differential expression of ferritin heavy chain in a rat transitional cell carcinoma progression model. (1997) (13)
- Has bromocriptine a place in the treatment of the unstable bladder? (1978) (13)
- Tolerability of 3.5 versus 2.5 High–Energy Transurethral Microwave Thermotherapy (2000) (13)
- Intravesical BCG administration in the guinea pig. A histomorphological study. (1988) (13)
- In vivo antiproliferative effects of gamma-interferon and tumor necrosis factor alpha in a rat renal cell carcinoma model system. (1990) (13)
- A computer model for describing the effect of urethral afferents on simulated lower urinary tract function. (1999) (13)
- Multifocal transitional cell cancer and p53 mutation analysis. (1998) (12)
- Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma. (1987) (12)
- A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life (2003) (12)
- Intravesical BCG administration in the guinea pig (1988) (12)
- Biological effects of high energy shock waves in mouse skeletal muscle: correlation between 31P magnetic resonance spectroscopic and microscopic alterations. (1993) (12)
- Management of superficial bladder cancer with intravesical chemotherapy: an update. (2000) (12)
- Comparison of the diagnostic value of pump and gravity cavernosometry in the evaluation of the cavernous veno-occlusive mechanism. (1991) (12)
- Consecutive quantitative cytology in bladder cancer. (2000) (12)
- Magnetic Resonance Imaging of Carcinoma of the Urinary Bladder (1990) (12)
- Lateral sinus thrombosis in the eighties (1985) (12)
- Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer. (1985) (12)
- 'Viable' tumor cells in posttherapy biopsy specimens. A potential application of human tumor clonogenic cell culture. (1983) (12)
- The Continuing Role of PSA in the Detection and Management of Prostate Cancer (2007) (12)
- Modelling selective activation of small myelinated nerve fibres using a monopolar point electrode (1995) (11)
- Ultrasonic determination of the residual bladder volume. (1989) (11)
- Pain sensation in transurethral microwave thermotherapy for benign prostatic hyperplasia: the rationale for prophylactic sedation. (1994) (11)
- Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations (2004) (11)
- Use of sacral reflex latency measurements in the evaluation of neural function of spinal cord injury patients: a comparison of neuro-urophysiological testing and urodynamic investigations. (1994) (11)
- Soft Agar Culture of Human Transitional Cell Carcinoma Colonies from Urine (1982) (11)
- The effects of successive high-energy shock-wave tumor administration on tumor blood flow. (1995) (11)
- Quality of life of patients with lower urinary tract dysfunction, after treatment with sacral neuromodulation (1997) (11)
- Recent developments in guidelines on benign prostatic hyperplasia (2002) (11)
- 349 Evaluation of the clinical benefit of Permixon and Tamsulosin in severe BPH patients. Permal study sub-set analysis (2004) (11)
- Otosclerosis: Shift in bone conduction after stapedotomy. (2015) (11)
- A shared care approach to the management of erectile dysfunction in the community (2002) (10)
- NEUROMODULATION EFFECTIVE IN VOIDING DYSFUNCTION DESPITE HIGH REOPERATION RATE (1999) (10)
- Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer? (1988) (10)
- Prevalence of risk factors for sensorineural hearing loss in NICU newborns. (2012) (10)
- Tonsillectomy compared to acute tonsillitis in children: a comparison study of societal costs. (2012) (10)
- Intermediate filament proteins as tissue specific markers in normal and neoplastic testicular tissue. (1987) (10)
- Sacral root stimulation in the dog: reduction of urethral resistance (1993) (10)
- HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF. (1991) (10)
- Antitumor effects of bacillus Calmette-Guerin in a syngeneic rat bladder tumor model system, RBT323. (1993) (10)
- Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group (2004) (10)
- Optimal management of superficial bladder cancer. (1991) (10)
- Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism. (1999) (9)
- Karyometry of bladder washings for the follow up of patients with transitional cell carcinoma of the bladder. (1992) (9)
- A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depot. (1990) (9)
- Determination of prostatic volume by ultrasonography. A useful procedure in patients with prostatism? (1989) (9)
- Histological analysis of ultrasonic images of the prostate: an accurate technique. (1990) (9)
- Fatal outcome of intravesical formalin instillation, with changes mimicking renal tuberculosis. (1986) (9)
- Urethral sphincteric responses to sacral root stimulation. (1991) (9)
- Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig (2004) (9)
- Weight characteristics of the parathyroid glands in renal hyperparathyroidism (2000) (9)
- Hormone Therapy: Improving Therapy Decisions and Monitoring (2006) (9)
- Pre-operative imaging in primary hyperparathyroidism with ultrasonography and sestamibi scintigraphy. (2011) (9)
- Lymphography in the management of urologic tumors. Radiological-pathological correlation. (1983) (9)
- Image analysis in superficial transitional cell carcinoma of the bladder. (1993) (9)
- The value of intravesical prostaglandin E2 and F2 alpha in women with abnormalities of bladder emptying. (1981) (9)
- Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. (1994) (9)
- Intrarenal arteriovenous fistula following renal allograft biopsy. (1978) (9)
- Medical management of BPH: the debate continues. (2006) (9)
- Recurrence of germ cell tumor after orchiectomy. (2000) (9)
- Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trials. (1997) (9)
- Frequency specificity and on-effect in brainstem electric response audiometry. (1982) (8)
- BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands. (1989) (8)
- Has the suprapubic suspension operation any influence on the urethral pressure profile? (1979) (8)
- BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group. (1989) (8)
- Effect of alpha- and gamma-interferon and tumor necrosis factor on colony formation of two human renal tumor xenografts in vitro. (1988) (8)
- Experssion of the human fes cellular oncogene in renal cell tumors (2004) (8)
- Antibiotic use and doctor visits are reduced after adenotonsillectomy. (2010) (8)
- General Principles of MRI (1990) (8)
- Urinary tract injuries in children: are they different from adults? (1988) (8)
- Intravesical chemotherapy for superficial bladder cancer (2004) (8)
- Molecular prognostic factor in renal cell carcinoma. (1996) (8)
- Renal hamartoma associated with renal cell (Grawitz) tumor: another indication that Grawitz tumors are carcinosarcomas. (1987) (8)
- Treatment of carcinoma in situ of the urethra with intraurethral instillations of bacillus Calmette-Guérin. Case report and review of literature. (1991) (8)
- Labyrinthine fistulae: a retrospective analysis. (1997) (7)
- Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urin (1998) (7)
- Intravesical BCG administration in the guinea pig (1992) (7)
- Successful pregnancy after renal transplantation in a patient with a urinary diversion. (1978) (7)
- [Anuria following appendectomy in a 10-year-old boy]. (1978) (7)
- Clinical experience in Europe with uroselective alpha1-antagonists. (1999) (7)
- The value of intravesical echography combined with double-surface coil magnetic resonance imaging in staging bladder cancer. (1989) (7)
- Noise exposure of care providers during otosurgical procedures. (2013) (7)
- 1552: The Efficacy and Safety of Ozarelix, a Novel GNRH Antagonist, in Men with Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (2007) (7)
- In vitro antiproliferative efficacy of Interferon-alpha,-gamma and Tumor Necrosis Factor on two human renal tumor xenografts (2004) (7)
- Comparative analysis of p53 mutations in bladder washings and histologic specimens. (1998) (7)
- Renal and gonadal venography in male infertility. (1981) (7)
- Soft-agar cultures of transitional cell carcinoma colonies from urine, irrigation fluids and tumor samples. (1983) (7)
- Current status of intravesical chemotherapy trials in the EORTC Urological Group. An Overview (2004) (7)
- Extracorporeal shock-wave lithotripsy for small symptomatic renal calculi: is it effective? (1991) (7)
- Influence of ketanserin (serotonin antagonist) on bladder and urethral function. (1987) (7)
- BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer. (1988) (6)
- The place of radical prostatectomy in the treatment of early localized prostate cancer. (2000) (6)
- Multidisciplinary evaluation of rat renal cell carcinoma. (1987) (6)
- Automated image analysis for bladder cancer (1998) (6)
- In Vitro Sensitivity of Three Human Renal Tumor Xenografts Towards Tumor Necrosis Factor and Alpha and Gamma Interferon (1989) (6)
- New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data. (1990) (6)
- Latency differences between ipsilateral and contralateral auditory brainstem responses. (1983) (6)
- Karyometry in recurrent superficial transitional cell tumors of the bladder (2004) (6)
- The value of laparoscopy in the management of the impalpable cryptorchid testis. (1992) (6)
- Fifteen years of early hearing screening in Flanders: impact on language and education. (2013) (6)
- Results of kidney transplantations in Nijmegen (1968-1981). (1982) (6)
- Legends in urology. (2015) (6)
- Current concepts in the management of paratesticular rhabdomyosarcoma. (1985) (6)
- Inhibition of rat bladder tumor (RBT323) growth by tumor necrosis factor alpha and interferon-gamma in vivo. (1992) (6)
- Kidney cancer mortality in The Netherlands, 1950-94: prediction of a decreasing trend. (1999) (5)
- The value of the bone scan. (1990) (5)
- Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig. (1992) (5)
- High energy shock waves induced increase in the local concentration of systemically given TNF-alpha. (1994) (5)
- Improved subjective responses to orchiectomy plus Nilutamide (Anadron) in comparison to orchiectomy plus placebo in metastatic carcinoma (1995) (5)
- Distribution of the solitary adenoma over the parathyroid glands (1997) (5)
- Interdependency between intensity and pitch in the normal speaking voice. (1998) (5)
- Age effect in speech audiometry and in brainstem electric response audiometry. (1989) (5)
- Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy. (1988) (5)
- Oncogene expression in prostate cancer (1991) (5)
- Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma. (1990) (5)
- Intravesical and intradermal Bacillus Calmette-Guérin application. A phase I study to the toxicity of a Dutch Bacillus Calmette-Guérin preparation in patients with superficial bladder cancer. (1988) (5)
- Review Article CURRENT STATUS OF THERMOTHEWY OF THE PROSTATE (1997) (5)
- Dynamics of human renal tumor colony growth in vitro (2004) (5)
- The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder (2004) (5)
- Luteinising hormone-releasing hormone analogues alone in the treatment of advanced disease. (1989) (5)
- Prognostic indicators of bladder cancer (1995) (4)
- Interferons in renal-cell carcinoma: status and prospects. (1990) (4)
- Results of a Dutch Trial With the LHRH Agonist Buserelin in Patients With Metastatic Prostatic Cancer and Results of EORTC Studies in Prostatic Cancer (1988) (4)
- Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma. (1994) (4)
- Induction of tumor regression by passive transfer of antibody from mice vaccinated with anti-idiotype antibodies resembling a human renal cell carcinoma-associated antigen. (1995) (4)
- Anovelimmmmunoenzymatic technique to demonstrate multiple antigens in cells based on selective destaining of substrate deposits and its application in characterization the immunophenotype of neuroendocrine cells in the human prostate epithelium (1998) (4)
- Cholesteatomas of the temporal bone: a comparison of CT and operative findings. (1991) (4)
- Increased expression of retroviral sequences in progressionally advanced rat prostatic tumors. (1992) (4)
- [Microperturbation of vocal cord vibrations, jitter and shimmer]. (1991) (4)
- Urological trauma and severe associated injuries. (1987) (4)
- Surgery in advanced disease for testicular cancer. (1990) (4)
- Sacral root stimulation for bladder control a study by computer modeling (1992) (4)
- Resolution of hypertension after percutaneous puncture of a solitary renal cyst. (1979) (4)
- Subspecialty certification in urology: a European perspective (2006) (4)
- Abstracts: Poster session (1992) (4)
- Multiparameter analysis of four human renal cell carcinoma xenografts in nude mice. (1987) (4)
- Prostaglandins in urology. (1986) (4)
- How and When to Take Prostate Biopsies (2002) (4)
- Practical Aspects of Urinary Incontinence (1986) (4)
- Progress in the imaging of the prostate gland (2003) (4)
- Use of luteinizing-hormone-releasing hormone nasal spray in the treatment of cryptorchidism: is there still an indication? A clinical study in 78 boys with 103 undescended testicles. (1990) (4)
- Unilateral hydroureteronephrosis resolved by fecal disimpaction in a patient with neurogenic bladder. (1983) (4)
- Keratin expression during neoplastic progression of bladder cancer. (1988) (4)
- BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands. (1992) (4)
- Phase I/II study of recombinant interferon α and γ in advanced progressive renal-cell carcinoma (1990) (3)
- 565Maintenance percutaneous tibial nerve stimulation (PTNS) treatment in successfully treated patients with refractory overactive bladder syndrome: A necessity (2005) (3)
- Underlying neurological dysfunction in children with language, speech or learning difficulties and a verbal IQ--performance IQ discrepancy. (2012) (3)
- Treatment of Nonneurogenic Unstable Bladder by Prolonged Bladder Distension (1978) (3)
- Cytogenetics of prostate cancer (1994) (3)
- 763Modulation of the micturition reflex in an anesthetized cat model through percutaneous stimulation of the tibial nerve (2005) (3)
- Original Articles: Bladder Cancer (1995) (3)
- [The ototoxicity of cisplatin: a clinical study]. (1990) (3)
- Improved subjective responses to orchiectomy plus nilutamide (anandron) in comparison to orchiectomy plus placebo in metastatic prostate cancer. International Anandron Study Group. (1995) (3)
- European Association of Urology (eau): 9th Congress, Amsterdam, June 1990: Abstracts (1990) (3)
- Repeated urine cell culture in soft agar: potential role in follow-up of patients with transitional cell carcinoma. (1985) (3)
- Role of mycoplasmas in chronic prostatitis. (1983) (3)
- Phase-locking of the auditory brain stem response. (1984) (3)
- Epidermoid cyst of the testis. (1978) (3)
- Hyperaldosteronism due to adrenocortical carcinoma 12 years after surgical removal of an aldosterone-producing adrenocortical adenoma. (1981) (3)
- Important factors in the diagnosis and primary staging of testicular tumours (2002) (3)
- A phase III randomized trial comparing the efficacy and safety of the 3-monthly 10.8-mg depot of Zoladex with the monthly 3.6-mg depot in patients with advanced prostate cancer. Dutch South East Cooperative Urological Group. (1994) (3)
- LHRH-analogues therapy for metastatic prostate cancer. (1988) (3)
- Image analysis and grading of prostate adenocarcinoma (1991) (3)
- [Normal values in brain stem electric response audiometry (BERA)]. (1980) (3)
- BCG (–RIVM) Versus MMc Intravesical Therapy in Patients with Superficial Bladder Cancer: First, Results of a Randomized Prospective Trial (1987) (3)
- Soft agar culture of human transitional cell carcinoma colonies from urine. (1983) (3)
- Ketoconazole high dose (H.D.) in the management of hormonally pretreated patients with progressive metastatic prostate cancer. (1987) (3)
- Effects of high-energy shock waves combined with biological response modifiers or Adriamycin on a human kidney cancer xenograft (2004) (3)
- [Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results]. (1986) (3)
- Some aspects of large cystocele and its treatment by colpo- or hysteropexy to the sacral promontory. (1981) (2)
- Synergistic antitumor effects of rat gamma-interferon and human tumor necrosis factor alpha against androgen-dependent and -independent rat prostatic tumors. (1991) (2)
- Transurethral microwave thermotherapy in benign prostatic hyperplasia (2000) (2)
- Intravesical and Intradermal Bacillus Calmette-Guérin Application (1988) (2)
- Antiproliferative effects of adriamycin and tumor necrosis factor alpha in a rat renal cell tumor model system (1990) (2)
- Increased expression of a 68-kDa protein in the corpus cavernosum of some men with erectile dysfunction. (1995) (2)
- Clinical observations on the on-off effect of the acoustic stapedius reflex. (1992) (2)
- Replacement of the early-control IVU after ureteral reimplantation by ultrasonography. (1989) (2)
- The predictive value of repeated urine cell culture in soft agar for recurrences of transitional cell carcinoma. (1989) (2)
- Estimation of the slope of the audiogram with the auditory brain stem response. (1984) (2)
- [High-frequency hearing thresholds prior to and following middle ear surgery]. (1993) (2)
- MP-20.02: The efficacy, duration of efficacy and safety of Ozarelix, a novel GnRH antagonist, in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) (2007) (2)
- Combined effects of tumor necrosis factor alpha and radiation in the treatment of renal cell carcinoma grown as radia spheroids. (1990) (2)
- Recent trends in the initial surgical treatment of primary hyperparathyroidism: a review. (2001) (2)
- Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer. (1987) (2)
- Minimally invasive urology. I. (1994) (2)
- Distal urethral stenosis in young girls. (1974) (2)
- Posterior tibial nerve stimulation in the treatment of overactive bladder and voiding dysfunction: Urodynamic data (2003) (2)
- Cryosurgery of prostatic carcinoma. (1984) (2)
- Posterior tibial nerve stimulation in the treatment of overactive bladder and voiding dysfunction: Urodynamic data (2003) (2)
- Use of animal models in diagnosis and treatment of renal cell carcinoma (1991) (2)
- Renal transplantation into an ileal conduit. (1977) (2)
- Selective stimulation of sacral roots (1992) (2)
- Extracorporeal shock wave lithotripsy of calculi in lower third of the ureter : randomized comparison of in situ treatment v treatment with loop catheter (1990) (2)
- Future of European Urology (2000) (2)
- Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. (2000) (2)
- Tinnitus maskers in the treatment of tinnitus. The MICROTEK 321Q. (1996) (2)
- 1359: Long-Term Therapy With the Dual 5 α -Reductase Inhibitor Dutasteride is Well Tolerated in Men With Symptomatic Benign Prostatic Hyperplasia (BPH) (2004) (2)
- Re-operation for secondary hyperparathyroidism (2007) (2)
- Renal injury management: no longer controversial. (1988) (2)
- Papillary cystadenoma of the epididymis. (1983) (2)
- New treatment approaches for superficial and invasive bladder cancer. (1998) (2)
- Role of α1-Adrenoceptors in the Future Treatment of Urological Diseases (1999) (2)
- 239 Testosterone treatment is not associated with increased risk of prostate cancer or cardiovascular events: Results from the Registry of Hypogonadism in Men (RHYME) (2015) (2)
- [Follow-up of trans-tympanum tubes]. (1986) (2)
- Updated prognostication of renal cell carcinoma patients (2002) (1)
- Prognosis in Patients with Prostate Cancer Decreased E-Cadherin Expression Is Associated with Poor Updated Version (2006) (1)
- Rational Antimicrobial Prophylaxis on a Urological Ward (1984) (1)
- Recurrent parathyroid hyperplasia after autotransplantation in the sternocleidomastoid muscle. (1996) (1)
- Models for prostate cancer. Molecular characterization and critical appraisal of humane prostate carcinoma cell lines (1987) (1)
- Selective sacral root stimulation for bladder control (1992) (1)
- Intracranial complications of otitis media. (1984) (1)
- Immunogenecity of G250 peptides: rationale for a dendritic cell peptide vaccine trial in patients with advanced renal cell carcinoma (2002) (1)
- 307 EFFICACY AND SAFETY OF AN ORODISPERSIBLE TABLET FORMULATION OF VARDENAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION (2010) (1)
- Identification of new prostate cancer progression markers by differential hybridization analysis. (1992) (1)
- Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview. (1990) (1)
- Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma (2004) (1)
- EXPRESSION OF N-CADHERIN IN HUMAN PROSTATE CANCER (1999) (1)
- Triplication and contralateral duplication of ureter. (1982) (1)
- Discussion, Conclusions and Future Prospects (1990) (1)
- Decreased Expression of a-Catenin is Associated With Poor Prognosis of Patients With Local- (1955) (1)
- PD-02.11 (2006) (1)
- 340 Long-term dutasteride therapy results in continued improvements in symptoms and peak urinary flow in men with symptomatic benign prostatic hyperplasia (2004) (1)
- Immunotherapy for metastatic renal cell carcinoma: a review. (1989) (1)
- [Molecular biology studies of bladder cancer]. (1991) (1)
- Labyrinthine fistulas in cholesteatoma (1997) (1)
- Expression of proto-oncogenes in xenografts of human renal cell carcinomas (1987) (1)
- Renal trauma in children (1990) (1)
- [Drug treatment of prostatic carcinoma]. (1997) (1)
- Interferon and Tumor Necrosis Factor in Renal Cell Carcinoma Model Systems (1991) (1)
- Risk factors for abnormal newborn hearing screening in the era of extended dose interval amikacin administration (2010) (1)
- MRI/US fusion transperineal prostate biopsies under local anesthesia (2017) (1)
- Successful management of postoperative hemorrhage of the kidney by selective transcatheter embolization. (1978) (1)
- Tools for Vaccination and Immunotherapy: Internal-Image Anti-idiotype Antibodies Resembling the Renal Cell Carcinoma Associated Antigen G250 (1994) (1)
- Basic research in urological oncology (1996) (1)
- Predictive factors of speech understanding in adults with cochlear implants. (2016) (1)
- [Diagnostic laparoscopy in non-palpable testis]. (1993) (1)
- A review of “upfront” chemotherapy in invasive transitional cell carcinoma of the bladder (1988) (1)
- Emergency management of lower urinary tract injuries. (1987) (1)
- Innovators in urology (1999) (1)
- Surgical Aspects of Transurethral Resection of Superficial Bladder Tumors (1988) (1)
- [Diagnosis of prostate cancer in urination disorders in urological practice: current status and future developments]. (1997) (1)
- The effect of ventilation tubes on otoacoustic emissions. A study of 106 ears in 62 children. (2004) (1)
- LHRH ANTAGONIST CETRORELIX FOR SYMPTOMATIC BPH: PROLONGED IMPROVEMENT BEYOND END OF TREATMENT IN PLACEBO-CONTROLLED TRIALS (2008) (1)
- Immunotherapy of renal cell carcinoma : clinical and experimental developments (1991) (1)
- 1290: PSA Velocity in BPH: Characteristics and its Value to Predict BPH-Related Invasive Therapy (2005) (1)
- [Transrectal echography of the prostate and its value in screening for prostatic carcinoma]. (1990) (1)
- Selective Stimulation And Blocking Of Sacral Nerves: Research Setup And Preliminary Results (1991) (1)
- The increased risk of surgery by PSA and prostate volume: Alfa- blocker and watchful waiting patients from real life clinical practice (2003) (1)
- Pre- and intra-operative findings in primary hyperparathyroidism. (2001) (1)
- [Congenital malformations of the stapes area]. (1988) (1)
- [Leakage of urine following kidney transplantation]. (1979) (1)
- Collecting voice data of normal elderly people (1998) (0)
- "I Believe in Britney" : Petits arrangements avec le fantasme marketing de la réification (2008) (0)
- BCG in superficial bladder cancer : proceedings of an EORTC Genitourinary Group sponsored meeting held at Erenstein Castle Kerkrade, the Netherlands, on September 7-8, 1988, organized by the Department of Urology, University of Nijmegen, the Netherlands (1989) (0)
- Intravesical therapy of superficial bladder cancer: a review (1995) (0)
- Intravesical and intradermal BCG-RIVM application: a toxicity study. (1985) (0)
- The influence of modelled feedback loops on simulated lower urinary tract behaviour (1997) (0)
- Serum parathyroid hormone and calcium during the first days after resection of a parathyroid adenoma. (1998) (0)
- BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer. (1987) (0)
- Prognostic Factors in Prostate Cancer (1996) (0)
- Quality of life after sigmond orhtotopic neobladder (short sigmoid segment single folded) (2003) (0)
- Automated image analysis of bladder washing for the early detection of bladder cancer (1995) (0)
- In Vitro Colony Growth Dynamics of the MATLyLu Tumor and Six New Dunning Rat Prostatic Tumor Cell Lines (1987) (0)
- 434 Efficient and selective targeting of a tumour-specific adenoviral expression vector to primary human renal cell carcinoma tumours (2004) (0)
- Organ preservation in superficial bladder cancer. (1991) (0)
- Basic principles of clinical trials as applied to testicular cancer. (1990) (0)
- Review of the current possibilities for arterial embolization in urology. (1979) (0)
- ORIGINAL RESEARCH—ED PHARMACOTHERAPY The POTENT I Randomized Trial: Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction (2010) (0)
- Sacral root stimulation for bladder control, a computer model (1993) (0)
- Results of a Dutch Trial With the LHRH Agonist Buserelin in Patients With Metastatic Prostatic Cancer and Results of RORTC Studies in Prostatic Cancer (1989) (0)
- SYMPTOMATIC PROSTATE CANCER PATIENTS (2004) (0)
- A model of the neural control of the lower urinary tract (1996) (0)
- Infected solitary cyst of the kidney. Review of the literature and three additional cases. (1980) (0)
- [Is Metz' test a recruitment test?]. (1979) (0)
- 326 Computer assisted versus conventional laparoscopic radical prostatectomy: A single surgeon's initial experience (2004) (0)
- Pitch and spectrum in the aging voice. A transversal and longitudinal research (1996) (0)
- Half-sine stimuli and wave I of the ABR. (1989) (0)
- Survival in Patients with Bladder Tumors Decreased E-Cadherin Immunoreactivity Correlates with Poor (2006) (0)
- Magnetic Resonance Spectroscopic Evaluation of the Effects of High-Energy Shock Waves Administered to a Human Kidney Cancer Xenograft (1993) (0)
- My congratulations to the German Society of Urology! (2006) (0)
- [The place of surgery in the treatment of testicular tumors other than seminoma (author's transl)]. (1979) (0)
- A RANDOMIZED STUDY OF INTRAWSICAL MITOMYCIN C, BACILLUS TREATMENT IN pTa-pT1 PAPILLARY CARCINOMA AND CARCINOMA IN SITU OF THE BLADDER CALMETTE-GUERIN TICE AND BACILLUS CALMETTE-GUERIN RIVM (1995) (0)
- Treatment of voiding dysfunction by neuromodulation and identification of predictive factors in a selected ms patient population (2003) (0)
- Chapter 45 – Neoadjuvant Hormonal Treatment Prior to Curative Treatment in Prostate Cancer (2003) (0)
- Erratum (0)
- The acoustic analysis of the elderly voice: quantitative results and how to understand them (1998) (0)
- DYNAMIC EXPRESSION OF KERATINS DURING HUMAN PROSTATE DEVELOPMENT (1999) (0)
- [Antibiotic prophylaxis in urology and rationalization of the antibiotics policy in a urological ward]. (1982) (0)
- Antitumor Effects of High-Energy Shock Waves are Potentiated by Doxorubicin and Biological Response Modifiers (1991) (0)
- [Proceedings: Asymptomatic bacteriuria in Amersfoort]. (1975) (0)
- CORRELATION BETWEEN ALCAM AND CADHERIN-MEDIATED ADHESION IN HUMAN BLADDER CANCER (1999) (0)
- [Indications for BERA]. (1981) (0)
- Oncology: bladder and testis (1999) (0)
- Endourology: New and Approved Techniques (1988) (0)
- 793 Does learning of clean intermittent catheterization (CIC) before pubovaginal sling surgery affect patient's choice for operation and post-operative perception of CIC? (2004) (0)
- Antegrade Resection of Posterior Urethral Valves (1988) (0)
- Normal Mr Images: Correlation with Kwown Anatomic Proportions (1990) (0)
- Clinical Urology: Letters to the EditorRE: RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER (1999) (0)
- Establishment andCharacterization of FiveNewHumanRenal TumorXenografts (1992) (0)
- 1960 SYMPTOM SCORE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (2017) (0)
- Durability of transurethral resection of the prostate: Is it a “definitive” treatment for luts due to BPH? (2003) (0)
- [Potential of magnetic resonance tomography in malignant tumors of the urinary bladder]. (1987) (0)
- The internet from a urologic perspective, special report (1996) (0)
- Introduction (1998) (0)
- Superficial bladder cancer: Diagnosis and staging. Cover story (1996) (0)
- Anandron: a new step in the treatment of advanced prostate cancer. (1991) (0)
- Technical Aspects of MRI Specific Relevant to Patients with Carcinoma of the Urinary Bladder (1990) (0)
- Automated images analysis of bladder washing for early detection of bladder cancer (1995) (0)
- 529: PCA3 Gene Based Analysis of Urinary Sediments has Prognostic Value (2005) (0)
- Postoperative levothyroxin replacement therapy after benign thyroid surgery (2005) (0)
- [The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma]. (1987) (0)
- Intravesical instillation therapy: alternative treatments. (1993) (0)
- PD-01.04 (2006) (0)
- EAU Strategy and Planning Committee Report (2001) (0)
- A phase II trial with monoclonal antibody WX-G250 in advanced renal cell carcinoma (2002) (0)
- Pelvic floor reeducation and body posture correction for treatment of female urinary incontinence: Results of comprehensive pre‐ and post‐treatment urodynamic testing (1992) (0)
- High frequency audiogram: effects of age and middle ear surgery (1997) (0)
- Clinical Assessment Deel 2 (2008) (0)
- 640Efficacy of peripheral nerve evaluation versus first stage tined lead in multiple sclerosis patients (2005) (0)
- Characterisation of intermediate cells in the human prostate epithelium: implications for prostate carcinogenesis and treatment (2002) (0)
- [Chemotherapy of testicular cancer]. (1999) (0)
- 292 Radio immunotherapy using 1311-CG250 in patients with metastasized renal cell carcinoma with two consecutive treatments at the maximum tolerated dose (2004) (0)
- Winds of change. Prognostic factors in bladder cancer (1995) (0)
- Tinnitus masker in the treatment of tinnitius (1996) (0)
- Long-term treatment with the LHRH-agonist buserelin in metastatic prostatic cancer (1986) (0)
- Panel IV: Locoregional disease (1992) (0)
- G250, A TUMOR ANTIGEN WITH THERAPEUTIC POTENTIAL IN RENAL CELL CARCINOMA (RCC) (1999) (0)
- Update. Superficial bladder cancer. Diagnosis and treatment with intravesical agents (1996) (0)
- Endocrine changes during treatment of prostate carcinoma (PCA) patients with the LHRH-agonist buserelin (HOE 766) (1986) (0)
- The use of the pedicled transverse island flap of the inner prepuce in hypospadias, epispadias and urethral stricture repair (1984) (0)
- Tracheo-esophageal speech with manual versus automatic stoma-occlusion : a multidimensional comparison (2008) (0)
- Soft agar cell culture from urine samples and the status of the urothelium of patients with transitional cell carcinoma (1984) (0)
- [Current trends in the treatment of paratesticular rhabdomyosarcoma]. (1985) (0)
- QUALITY OF LIFE ASSESSMENT IN APROSPECTIVE RANDOMIZED STUDY COMPARING HIGH ENERGY TRANSURETHRAL THERMOTHERAPY (HE-TUMT) TO TRANSURETHRAL RESECTION OF THE PROSTATE (TURP). (1998) (0)
- [The future of urology in Europe: a perspective from the European Urology Association]. (2001) (0)
- Reduced or Absent in High-Grade Prostate Cancer Expression of the Cellular Adhesion Molecule E-Cadherin Is Updated (2006) (0)
- Epidemiology of the bladder tumors. (1990) (0)
- Labyrinthine fistula and pre- and postoperative bone conduction (1985) (0)
- URODYNAMIC EVALUATION OF VOIDING FUNCTION IN FEMALES WITH STRESS URINARY INCONTINENCE (2003) (0)
- THE PREDICTION OF CLINICAL OUTCOME FROM TRANSURETHRAL EUROPEAN MULTICENTER STUDY MICROWAVE THERMOTHERAPY BY PRESSURE-FLOW ANALYSIS: A (1995) (0)
- Gene expression in superficial bladder cancer in a tumor-model-system (RBT). (1994) (0)
- 1401: A Phase I/II Study of a Chimeric Antibody Against Interleukin-6 (CNTO 328) in Subjects with Metastatic Renal Cell Carcinoma (2005) (0)
- [Inductive chemotherapy of bladder cancer. A critical evaluation]. (1991) (0)
- 招聘講演1 Renal Cell Carcinoma; New Clinical and Investigative Approaches. (1994) (0)
- Complete hormonal blockage--antiandrogens. (1996) (0)
- [Hormone treatment of prostate carcinoma: past achievements and current perspectives]. (1986) (0)
- Future aspects of TUMT treatment of benign prostatic hypertrophy (1998) (0)
- Locoregional disease. (1992) (0)
- Editorial: Prostate Cancer--Staging and Prognosis (1996) (0)
- Tunes of Globalization (2015) (0)
- [Over- and underestimation of hearing using the click-evoked brain stem P5]. (1984) (0)
- [Kidney injury and hypertension]. (1987) (0)
- The outcome of treatment of elderly male with lower urinary tract symptoms when the urodynamic diagnosis is included in the stratification for therapy (1997) (0)
- 60: Urodynamic Behaviour of a Sigmoid Neobladder (Short Distal Detubularized Sigmoid (2004) (0)
- Staging of Carcinoma of the Urinary Bladder on the Basis of MRI Results (1990) (0)
- Review Article Role of Testosterone in Managing Advanced Prostate Cancer (2012) (0)
- Long term results of ileal substitution as a treatment for ureteral obstruction (2002) (0)
- CLINICAL RESULTS OF STRATEGIES TO OPTIMIZE HIGH ENERGY TRNSURETHRAL MICROWAVE THERMOTHERAPY (HE-TUMT) (1998) (0)
- Obesity and the metabolic syndrome in older men (2017) (0)
- [Microscopic hematuria following blunt abdominal injury]. (1985) (0)
- Long Term Follow-Up of Bladder Cancer Patients with Urine Cell Culture in Soft Agar (1987) (0)
- HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY (TUMT) IN THE TREATMENT OF BPH PATIENTS RESULTS AFTER 2 YEARS FOLLOW-UP. (1997) (0)
- Extended Bladder Neek Incision for Outflow Obstruction in Male Patients (1984) (0)
- Limitations of surgical curability in renal cell carcinoma. (1992) (0)
- Intravesical BCG administration in the guinea pig. Histomorphological aspects. (1989) (0)
- Sacral root stimulation for bladder control experimental results (1992) (0)
- [Chemoprophylaxis of superficial bladder tumors. Results of the EORTC study]. (1986) (0)
- [Acute mastoiditis: 16 clinical cases]. (1985) (0)
- Sensorineural hearing loss insporadic congenital hypothyroidism (1983) (0)
- Reply (2010) (0)
- Phase II Study of Interferon Alpha-2 (IFN) and Vinblastine (V) in Advanced Renal Carcinoma (ARC) (1987) (0)
- Immunoscintigraphy and biodistribution of three 99mTc-G250 mAb preparations in nude mice with SC RCC tumors (1998) (0)
- [Differential diagnosis and therapy in acute disorders of the scrotum]. (1988) (0)
- 415Large postvoid residual urine volumes: Does it affect clinical progression of treated and untreated BPH? (2005) (0)
- [Audiological and pedagogical implications of slight perceptual deafness]. (1988) (0)
- Surgical findings and postoperative parathormone levels in patients operated for secondary hyperparathyroidism (2009) (0)
- The treatment of chronic pyelonephritis with carindacillin. (1978) (0)
- [Percutaneous removal of kidney stones]. (1986) (0)
- Overview of the current status of total androgen deprivation in metastasized prostate cancer (2004) (0)
- Non medical treatment in BPH; new techniques and developments (1997) (0)
- Functional vesico-urethral pathology and the influence on the urinary tract in children. (1989) (0)
- QUANT 1 CYT : KARYOMETRIC ANALYSIS OF BLADDER WASHING FOR PATIENTS WITH SUPERFICIAL BLADDER CANCER (2017) (0)
- Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review (2022) (0)
- Oncology: Prostate and renal (1991) (0)
- HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY (TUMT) VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) (1997) (0)
- Otosclerosis: shift in bone conduction before and after stapedotomy (2014) (0)
- [Kidney stone surgery: still necessary or superfluous?]. (1986) (0)
- [How to treat infiltrating cancer of the bladder?]. (1996) (0)
- New techniques and developments in the non-medical treatment of benigng prostatic hyperplasia (1997) (0)
- Canine bladder evacuation by electrical stimulation of the ventral sacral nerve roots (1994) (0)
- Future aspects in the management of urinary incontinence (1986) (0)
- Intravesical therapy in superficial bladder cancer. Commentary (1994) (0)
- Assessment of the diagnostic, prognostic and therapeutic usefulness of DD3 for prostate cancer. (1999) (0)
- 923A phase 1/2 study of a chimeric antibody against interleukin-6 (CNTO 328) in subjects with metastatic renal cell carcinoma (2005) (0)
- Prediction of Cytokine-Therapy on Basis of Class-I and Class-II MHC Antigen Induction (1992) (0)
- Advances in Brief Decreased E-Cadherin Immunoreactivity Correlates with Poor Survival in Patients with Bladder (2006) (0)
- [Urologic tumors in old age]. (1986) (0)
- Highlights from the 20th International Prostate Cancer Update (2010) (0)
- [The treatment of kidney and ureteral stones using a second-generation kidney stone lithotriptor]. (1990) (0)
- Prophylactic Ultrasound Screening of Prostate Cancer (1991) (0)
- [Once more kidney stone lithotripsy]. (1990) (0)
- Current concepts in the management of paratesticular rhabdomyosarcoma. (1985) (0)
- QUANT1CYT: KARYOMETRIC ANALYSIS OF BLADDER WASHING FOR PATIENTS WITH SUPERFICIAL BLADDER CANCER (2019) (0)
- [Brain stem evoked response for audiometric testing]. (1981) (0)
- Hearing impairment following contemporary neonatal intensive care: any relation to drug use ? (2009) (0)
- SP1-2 Recent trends and future of the European Association of Urology (EAU)(Special Program 1「Recent Trends and The Future of AUA, EAU, UAA and JUA」) (2006) (0)
- ORIGINAL RESEARCH—COUPLES' SEXUAL DYSFUNCTIONS Improvement in Sexual Quality of Life of the Female Partner Following Vardenafil Treatment of Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Study (2011) (0)
- The Use of Monoclonal Antibody G 250 in the Therapy of Renal-Cell Carcinoma (2017) (0)
- Cancer superficial de Bexiga (1997) (0)
- Secondary hyperparathyroidism: operative and postoperative findings (2007) (0)
- Prostaglandins in Urology (1987) (0)
- Historical note: the beginning of parathyroidectomy. (2001) (0)
This paper list is powered by the following services:
